Engineered nanoparticles for the treatment of Alzheimer’s disease
Frontiers in Pharmacology · 03.04.2025 · 16
DOI: 10.3389/fphar.2025.1510798 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 03.04.2025. Verfasst von Jia Jia und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Function Examination, The Fourth Affiliated Hospital of China Medical University, Shenyang, China. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is one of the most common diseases characterized by neurodegeneration and is becoming a major public health problem worldwide. AD is manifested mainly by progressive impairments in cognition, emotion, language and memory in the elderly population. Many treatment strategies have been explored for decades; however, there is still no effective way to address the root cause of AD pathogenesis, only to target symptoms to improve patient cognitive outcomes. Intracerebral administration is difficult because of the challenges posed by the blood‒brain barrier (BBB). NPs are materials with sizes between 1 and 100 nm that can improve biocompatibility, extend the half-life, transport macromolecules, be delivered across the BBB to the central nervous system, and exhibit good targeting capabilities. NPs can provide new ideas for the treatment of AD in terms of their antiaging, antineuroinflammatory, antioxidative, and nerve repair-promoting effects. In this manuscript, we first describe the relationship between AD and the BBB. Second, we introduce the application of nanoparticles for AD treatment. Finally, we summarize the challenges faced by nanoparticles in the treatment of AD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurological Function Examination, The Fourth Affiliated Hospital of China Medical University, Shenyang, China.
- Endoscopy Center, The Fourth Affiliated Hospital of China Medical University, Shenyang, China.
- Fifth Department of General Surgery, The Fourth Affiliated Hospital of China Medical University, Shenyang, China.
- Second Department of General Surgery, The Fourth Affiliated Hospital of China Medical University, Shenyang, China.
Zitieren
APA
Jia, J., Zhao, S., Zhao, J., & Gao, Y. (2025). Engineered nanoparticles for the treatment of Alzheimer’s disease. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1510798
Vancouver
Jia J, Zhao S, Zhao J, Gao Y. Engineered nanoparticles for the treatment of Alzheimer’s disease. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1510798
BibTeX
@article{Jia2025,
author = {Jia, Jia and Zhao, Shuang and Zhao, Jinghan and Gao, Yun},
title = {Engineered nanoparticles for the treatment of Alzheimer’s disease},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1510798}
}
EUVIMED